Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer
Sign Up to like & getrecommendations! Published in 2022 at "Oncoimmunology"
DOI: 10.1080/2162402x.2022.2034355
Abstract: ABSTRACT Retargeting of T lymphocytes toward cancer cells by bispecific antibodies has demonstrated its therapeutic potential, with one such antibody approved for the treatment of acute lymphoblastic leukemia (blinatumomab) and several other in clinical trials.… read more here.
Keywords: cancer; cell engagers; tumor; cell ... See more keywords